Sex-Gender Differences in Irritable Bowel Syndrome

Overview

Journal J Neurogastroenterol Motil

Date 2018 Oct 24

PMID 30347934

Citations 118

Authors

Young Sun Kim

Nayoung Kim

Affiliations

Soon will be listed here.

Abstract

Because of the sex-gender differences that are shown in a diversity of physiological and psychological factors, it can be speculated that the clinical presentation of symptoms as well as treatment strategies in women and men with irritable bowel syndrome (IBS) may differ. Studies have revealed that IBS is more common in women than men. As for the IBS subtype, IBS with constipation is significantly more prevalent among women than men. Sex hormones and gender differences may play important roles in the pathophysiology of IBS. However, its pathophysiologic mechanisms still remain largely unknown, and therapeutic implications are limited. Moreover, women IBS patients have been reported to feel more fatigue, depression, anxiety, and lower quality of life than men IBS patients. Furthermore, there has been evidence of differences in the appropriate treatment efficacy to IBS in men and women, although relatively few men are enrolled in most relevant clinical trials. A more sex-gender-oriented approach in the medical care setting could improve understanding of heterogeneous patients suffering from IBS. An individualized and multicomponent approach including sex and gender issues might help improve the treatment of IBS.

Citing Articles

Aspects on Self-Reported Symptoms in Irritable Bowel Syndrome: A Cross-Sectional Study.

Someili A, Mutaen A, Alqahtani A, Mobaraki R, Mutaen Y, Almuhaysin G Gastroenterology Res. 2025; 18(1):31-37.

PMID: 40051890 PMC: 11882227. DOI: 10.14740/gr2010.

Brain Morphometry and Cognitive Features in the Prediction of Irritable Bowel Syndrome.

Lundervold A, Bjorsvik B, Billing J, Berentsen B, Lied G, Steinsvik E Diagnostics (Basel). 2025; 15(4).

PMID: 40002622 PMC: 11854466. DOI: 10.3390/diagnostics15040470.

Risk factors for developing irritable bowel syndrome: systematic umbrella review of reviews.

Sulaimi F, Ong T, Tang A, Quek J, Pillay R, Low D BMC Med. 2025; 23(1):103.

PMID: 39985070 PMC: 11846330. DOI: 10.1186/s12916-025-03930-5.

Sex-specific transcriptome similarity networks elucidate comorbidity relationships.

Sanchez-Valle J, Flores-Rodero M, Costa F, Carbonell-Caballero J, Nunez-Carpintero I, Tabares-Seisdedos R bioRxiv. 2025; .

PMID: 39896586 PMC: 11785135. DOI: 10.1101/2025.01.22.634077.

The relationship between night eating behavior, gastrointestinal symptoms, and psychological well-being: insights from a cross-sectional study in Türkiye.

Ekici E, Mengi Celik O, Metin Z J Eat Disord. 2025; 13(1):14.

PMID: 39856759 PMC: 11762470. DOI: 10.1186/s40337-024-01158-x.

References

Qi Q, Zhang Y, Chen F, Zuo X, Li Y . Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol. 2018; 18(1):5. PMC: 5759234. DOI: 10.1186/s12876-017-0734-2. View

Kim B, Rhee P, Park J, Kyung Chang D, Kim Y, Son H . Male sex hormones may influence the symptoms of irritable bowel syndrome in young men. Digestion. 2008; 78(2-3):88-92. DOI: 10.1159/000166600. View

Martin-Vinas J, Quigley E . Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. J Dig Dis. 2016; 17(9):572-581. DOI: 10.1111/1751-2980.12379. View

Cremon C, Gargano L, Morselli-Labate A, Santini D, Cogliandro R, De Giorgio R . Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009; 104(2):392-400. DOI: 10.1038/ajg.2008.94. View

Houghton L, Heitkemper M, Crowell M, Emmanuel A, Halpert A, McRoberts J . Age, Gender and Women's Health and the Patient. Gastroenterology. 2016; . DOI: 10.1053/j.gastro.2016.02.017. View

Park J, Choi M, Kim Y, Choi C, Choi S, Hong S . Quality of life of patients with irritable bowel syndrome in Korea. Qual Life Res. 2009; 18(4):435-46. DOI: 10.1007/s11136-009-9461-7. View

Markle J, Frank D, Mortin-Toth S, Robertson C, Feazel L, Rolle-Kampczyk U . Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013; 339(6123):1084-8. DOI: 10.1126/science.1233521. View

Ustun T . Cross-national epidemiology of depression and gender. J Gend Specif Med. 2001; 3(2):54-8. View

Meibohm B, Beierle I, Derendorf H . How important are gender differences in pharmacokinetics?. Clin Pharmacokinet. 2002; 41(5):329-42. DOI: 10.2165/00003088-200241050-00002. View

10.

Scott L, Perry C . Tegaserod. Drugs. 1999; 58(3):491-6; discussion 497-8. DOI: 10.2165/00003495-199958030-00013. View

11.

Chang L, Heitkemper M . Gender differences in irritable bowel syndrome. Gastroenterology. 2002; 123(5):1686-701. DOI: 10.1053/gast.2002.36603. View

12.

Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K . Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2013; 12(6):953-9.e4. DOI: 10.1016/j.cgh.2013.11.024. View

13.

Anderson G . Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt). 2005; 14(1):19-29. DOI: 10.1089/jwh.2005.14.19. View

14.

Olafsdottir L, Gudjonsson H, Jonsdottir H, Bjornsson E, Thjodleifsson B . Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study. Gastroenterol Res Pract. 2012; 2012:534204. PMC: 3312222. DOI: 10.1155/2012/534204. View

15.

Drossman D, Camilleri M, Mayer E, Whitehead W . AGA technical review on irritable bowel syndrome. Gastroenterology. 2002; 123(6):2108-31. DOI: 10.1053/gast.2002.37095. View

16.

Choi Y, Park Y, Kim N, Kim Y, Lee S, Lee D . Gender differences in ghrelin, nociception genes, psychological factors and quality of life in functional dyspepsia. World J Gastroenterol. 2017; 23(45):8053-8061. PMC: 5725300. DOI: 10.3748/wjg.v23.i45.8053. View

17.

Gonenne J, Esfandyari T, Camilleri M, Burton D, Stephens D, Baxter K . Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil. 2006; 18(10):911-8. DOI: 10.1111/j.1365-2982.2006.00808.x. View

18.

Adeyemo M, Spiegel B, Chang L . Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?. Aliment Pharmacol Ther. 2010; 32(6):738-55. PMC: 2932820. DOI: 10.1111/j.1365-2036.2010.04409.x. View

19.

Yamada E, Tsunoda S, Abe T, Uchida E, Teraoka H, Watanabe S . Factors associated with poor therapeutic response in outpatients with irritable bowel syndrome: a multicenter study in Japan. J Gastroenterol. 2016; 52(3):301-307. DOI: 10.1007/s00535-016-1215-z. View

20.

Heitkemper M, Chang L . Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome?. Gend Med. 2009; 6 Suppl 2:152-67. PMC: 3322543. DOI: 10.1016/j.genm.2009.03.004. View